Can bone scans guide therapy with radium-223 dichloride for prostate cancer bone metastases?

Overview of attention for article published in Cancer Management and Research, September 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Frequency of superscan on bone scintigraphy: A systematic review

Article in Clinical Physiology and Functional Imaging (April 2023)

Radionuclide Therapy with Alpha-Emitting Agents in Bone Metastasis

Book chapter (August 2022)

Three years' clinical practice of Radium-223 therapy in patients with symptomatic bone metastases from metastatic castrate-resistant prostate cancer: a single-centre experience.

Article in Nuclear Medicine Communications (April 2020)